Author Archive

No early win for Sanofi, Regeneron cholesterol drug in study

(Reuters) - Sanofi and Regeneron Pharmaceuticals said on Thursday they would continue a large clinical outcomes study with their injectable cholesterol-lowering drug Praluent. There had been an option for the trial to be stopped early if

UPS air maintenance workers vote 98 percent to authorize strike

Air maintenance workers at United Parcel Service Inc have voted overwhelmingly to authorize a strike against the world's largest package delivery company as contract talks remained deadlocked over health-care benefits, the workers' union said on Monday.

New guidelines: Introduce peanuts to infants early to prevent allergies

By Rob Goodier (Reuters Health) – Parents may be able to reduce the chance that their children will develop peanut allergies by introducing the food early on, as young as four to six months of age, experts

AbbVie’s hepatitis C treatment shows promise

(Reuters) - Drugmaker AbbVie Inc said on Friday its experimental fixed-dose combination to treat certain hepatitis C virus patients achieved high sustained viral response (SVR) rates after eight weeks of treatment. The once-daily fixed-dose combination, glecaprevir/pibrentasvir (G/P),

Mosul families squat in squalor between frontline and camps

By John Davison SHAHREZAD, Iraq (Reuters) - At the small mosque in Shahrezad village, piles of human faeces dot the toilets and rubbish is strewn around the garden. Fifty people are crammed into an abandoned and bombed-out

Expert Views: What will be the impact of Trump presidency on immigration, refugees?

By Ellen Wulfhorst and Sebastien Malo NEW YORK (Thomson Reuters Foundation) - The election of Republican Donald Trump to be the next U.S. president raises questions about the impact his administration could have upon immigrants in

Audi CEO to face renewed VW emissions inquiry: sources

Audi Chief Executive Rupert Stadler will again be questioned by U.S. law firm Jones Day on a reported discovery of a new cheat software device at the luxury car brand, two people familiar with the matter

Exclusive: Pfizer weighs sale or spin-off of consumer health unit – sources

By Lauren Hirsch, Olivia Oran and Carl O'Donnell (Reuters) - U.S. drugmaker Pfizer Inc is evaluating a potential sale or spin-off of its consumer health division that could value the unit at as much as $14

Mylan working to finalize EpiPen Medicaid settlement: CFO

Generic drugmaker Mylan NV said on Wednesday it was working to finalize a settlement with the U.S. government over Medicaid rebates for its EpiPen emergency allergy treatment, adding that money set aside for the settlement led to

New Delhi targets older diesel vehicles to clear up choking smog

By Sanjeev Miglani NEW DELHI (Reuters) - Authorities in New Delhi began revoking licenses for thousands of older diesel vehicles on Tuesday and halted construction work on the underground rail network, as air pollution remained several